Clinical Evaluation of Placement of Radiofrequency-based Plasma Microdebridement in the Treatment Algorithm for Foot and Ankle Tendinosis and Plantar Fasciosis

Inclusion Criteria: * Subject is at least 18 years of age * Subject's history and physical examination pinpoints anatomic origin of heel pain as associated with plantar fasciosis (tenderness with palpation and local pressure over the medial calcaneal tuberosity on passive dorsiflexion) or Achilles tendinosis (tenderness upon palpation and local pressure at the insertion site) * Subject (or guardian) must sign IRB approved informed consent form * Subject is willing and able to complete required follow-up Exclusion Criteria: * Previous fascia surgery on pathology to be treated by this study * Multiple anatomic origins of heel pain in foot to be treated by study * History or documentation showing Type I and Type II Diabetes Mellitus * Physical findings and documentation of coagulopathy, infection, tumor or other systemic disease(s) * History or documentation showing peripheral vascular disease or autoimmune disease * History or documentation of fibromyalgia * Subject is currently participating in another drug/device study related to the injured plantar fascia or Achilles tendon * Pregnant or pregnant suspected subjects prior to treatment * Subject is incapable of understanding or responding to the study questionnaires